Xiusong Tang
Nanning, 530000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Loureirin A, derived from Dragon's blood, promoted drug delivery and efficacy in pancreatic cancer via vascular promotion.
Journal: Biochemical and biophysical research communications
Published: March 02, 2026
Potential therapeutic mechanisms of Draconis Resina in cardiovascular diseases-a narrative review.
Journal: Frontiers in pharmacology
Published: November 21, 2024
Loureirin B Reduces Insulin Resistance and Chronic Inflammation in a Rat Model of Polycystic Ovary Syndrome by Upregulating GPR120 and Activating the LKB1/AMPK Signaling Pathway.
Journal: International journal of molecular sciences
Published: August 28, 2024
Network pharmacology and experimental validation to elucidate the mechanism of the treatment of polycystic ovary syndrome with insulin resistance by Resina Draconis.
Journal: Journal of ovarian research
Published: August 06, 2024
Integrated serum pharmacochemistry and network pharmacology to explore the mechanism of Yi-Shan-Hong formula in alleviating chronic liver injury.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 15, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026